Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Cytosorbents (CTSO) over the last 15 years, with Q3 2025 value amounting to $55000.0.

  • Cytosorbents' Cash from Investing Activities rose 11839.46% to $55000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$248430.0, marking a year-over-year increase of 6351.56%. This contributed to the annual value of -$669430.0 for FY2024, which is 2849.77% up from last year.
  • Per Cytosorbents' latest filing, its Cash from Investing Activities stood at $55000.0 for Q3 2025, which was up 11839.46% from -$131758.0 recorded in Q2 2025.
  • Cytosorbents' Cash from Investing Activities' 5-year high stood at $140285.0 during Q2 2023, with a 5-year trough of -$4.7 million in Q2 2022.
  • In the last 5 years, Cytosorbents' Cash from Investing Activities had a median value of -$257715.0 in 2023 and averaged -$656131.7.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first tumbled by 52853.17% in 2021, then surged by 11839.46% in 2025.
  • Quarter analysis of 5 years shows Cytosorbents' Cash from Investing Activities stood at -$1.7 million in 2021, then surged by 87.68% to -$206080.0 in 2022, then skyrocketed by 34.04% to -$135922.0 in 2023, then grew by 8.45% to -$124430.0 in 2024, then surged by 144.2% to $55000.0 in 2025.
  • Its Cash from Investing Activities was $55000.0 in Q3 2025, compared to -$131758.0 in Q2 2025 and -$47242.0 in Q1 2025.